{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T07:36:19Z","timestamp":1791876979372,"version":"4.3.4"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81220108003"],"award-info":[{"award-number":["81220108003"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["30930043"],"award-info":[{"award-number":["30930043"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Natural Science Fund of Shanghai Committee of Science and Technology","award":["12ZR1442100"],"award-info":[{"award-number":["12ZR1442100"]}]},{"name":"Research Fund for Excellent Doctor of Shanghai Medical College of Fudan University","award":["EZF152300002001"],"award-info":[{"award-number":["EZF152300002001"]}]}],"content-domain":{"domain":["jmmc-online.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Molecular and Cellular Cardiology"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1016\/j.yjmcc.2016.05.012","type":"journal-article","created":{"date-parts":[[2016,5,21]],"date-time":"2016-05-21T08:33:51Z","timestamp":1463819631000},"page":"180-190","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":130,"special_numbering":"C","title":["The effects of different angiotensin II type 1 receptor blockers on the regulation of the ACE-AngII-AT1 and ACE2-Ang(1\u20137)-Mas axes in pressure overload-induced cardiac remodeling in male mice"],"prefix":"10.1016","volume":"97","author":[{"given":"Xingxu","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shijun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peipei","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiwen","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Le","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiu","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weijing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junbo","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunzeng","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yjmcc.2016.05.012_bb0005","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1111\/bph.12346","article-title":"Chronic inhibition of cGMP-specific phosphodiesterase 5 suppresses endoplasmic reticulum stress in heart failure","volume":"170","author":"Gong","year":"2013","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.yjmcc.2016.05.012_bb0010","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1161\/CIRCRESAHA.108.184911","article-title":"Angiotensin(1\u20137) blunts hypertensive cardiac remodeling by a direct effect on the heart","volume":"103","author":"Mercure","year":"2008","journal-title":"Circ. Res."},{"key":"10.1016\/j.yjmcc.2016.05.012_bb0015","article-title":"ACE2-Ang (1\u20137) axis is induced in pressure overloaded rat model","volume":"8","author":"Liang","year":"2015","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"10.1016\/j.yjmcc.2016.05.012_bb0020","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1152\/physrev.00036.2005","article-title":"Physiology of local renin-angiotensin systems","volume":"86","author":"Paul","year":"2006","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.yjmcc.2016.05.012_bb0025","doi-asserted-by":"crossref","first-page":"3A","DOI":"10.1016\/S0002-9149(01)02321-9","article-title":"The role of the renin-angiotensin system in the development of cardiovascular disease","volume":"89","author":"Unger","year":"2002","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.yjmcc.2016.05.012_bb0030","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1161\/CIRCULATIONAHA.108.822676","article-title":"Current perspectives on cardiac function in patients with diastolic heart failure","volume":"119","author":"Wang","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2016.05.012_bb0035","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1038\/nrd873","article-title":"Drugs targeting the renin-angiotensin-aldosterone system","volume":"1","author":"Zaman","year":"2002","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.yjmcc.2016.05.012_bb0040","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.atherosclerosis.2012.08.018","article-title":"Angiotensin converting enzyme 2 and atherosclerosis","volume":"226","author":"Wang","year":"2013","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.yjmcc.2016.05.012_bb0045","doi-asserted-by":"crossref","first-page":"33238","DOI":"10.1074\/jbc.M002615200","article-title":"A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase","volume":"275","author":"Tipnis","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.yjmcc.2016.05.012_bb0050","doi-asserted-by":"crossref","first-page":"14838","DOI":"10.1074\/jbc.M200581200","article-title":"Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase","volume":"277","author":"Vickers","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.yjmcc.2016.05.012_bb0055","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/hr.2009.74","article-title":"Devil and angel in the renin-angiotensin system: ACE-angiotensin II-AT1 receptor axis vs. ACE2-angiotensin-(1\u20137)-Mas receptor axis","volume":"32","author":"Iwai","year":"2009","journal-title":"Hypertens. Res."},{"key":"10.1016\/j.yjmcc.2016.05.012_bb0060","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/hr.2010.235","article-title":"ACE2-angiotensin-(1\u20137)-Mas axis and oxidative stress in cardiovascular disease","volume":"34","author":"Rabelo","year":"2011","journal-title":"Hypertens. Res."},{"key":"10.1016\/j.yjmcc.2016.05.012_bb0065","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1432869100","article-title":"Angiotensin-(1\u20137) is an endogenous ligand for the G protein-coupled receptor Mas","volume":"100","author":"Santos","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.yjmcc.2016.05.012_bb0070","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S1050-1738(02)00233-5","article-title":"The role of ACE2 in cardiovascular physiology","volume":"13","author":"Oudit","year":"2003","journal-title":"Trends Cardiovasc. Med."},{"key":"10.1016\/j.yjmcc.2016.05.012_bb0075","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1113\/expphysiol.2008.042002","article-title":"Recent advances in the angiotensin-converting enzyme 2-angiotensin(1\u20137)-Mas axis","volume":"93","author":"Santos","year":"2008","journal-title":"Exp. Physiol."},{"key":"10.1016\/j.yjmcc.2016.05.012_bb0080","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.jacc.2008.02.088","article-title":"Detection of soluble angiotensin-converting enzyme 2 in heart failure: insights into the endogenous counter-regulatory pathway of the renin-angiotensin-aldosterone system","volume":"52","author":"Epelman","year":"2008","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.yjmcc.2016.05.012_bb0085","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCULATIONAHA.110.955369","article-title":"Angiotensin-converting enzyme 2 suppresses pathological hypertrophy, myocardial fibrosis, and cardiac dysfunction","volume":"122","author":"Zhong","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2016.05.012_bb0090","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.yjmcc.2010.12.003","article-title":"Targeting the ACE2-Ang-(1\u20137) pathway in cardiac fibroblasts to treat cardiac remodeling and heart failure","volume":"51","author":"Iwata","year":"2011","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.yjmcc.2016.05.012_bb0095","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.7150\/ijbs.7.1077","article-title":"Cardioprotective effects of telmisartan against heart failure in rats induced by experimental autoimmune myocarditis through the modulation of angiotensin-converting enzyme-2\/angiotensin 1\u20137\/mas receptor axis","volume":"7","author":"Sukumaran","year":"2011","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.yjmcc.2016.05.012_bb0100","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1097\/HJH.0b013e32834bbb4d","article-title":"Role of angiotensin-converting enzyme 2 in cardiac hypertrophy induced by nitric oxide synthase inhibition","volume":"29","author":"Inaba","year":"2011","journal-title":"J. Hypertens."},{"key":"10.1016\/j.yjmcc.2016.05.012_bb0105","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.mce.2011.12.010","article-title":"Olmesartan attenuates the development of heart failure after experimental autoimmune myocarditis in rats through the modulation of ANG 1\u20137 mas receptor","volume":"351","author":"Sukumaran","year":"2012","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.yjmcc.2016.05.012_bb0110","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1161\/CIRCULATIONAHA.104.510461","article-title":"Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2","volume":"111","author":"Ferrario","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2016.05.012_bb0115","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1038\/aps.2011.96","article-title":"Regulation of angiotensin-(1\u20137) and angiotensin II type 1 receptor by telmisartan and losartan in adriamycin-induced rat heart failure","volume":"32","author":"Zong","year":"2011","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.yjmcc.2016.05.012_bb0120","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.bbrc.2010.05.097","article-title":"Mechanical stress-evoked but angiotensin II-independent activation of angiotensin II type 1 receptor induces cardiac hypertrophy through calcineurin pathway","volume":"397","author":"Zhou","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.yjmcc.2016.05.012_bb0125","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1177\/1753944708098691","article-title":"Olmesartan improves left ventricular function in pressure-overload hypertrophied rat heart by blocking angiotensin II receptor with synergic effects of upregulation of angiotensin converting enzyme 2","volume":"3","author":"Kaiqiang","year":"2009","journal-title":"Ther. Adv. Cardiovasc. Dis."},{"key":"10.1016\/j.yjmcc.2016.05.012_bb0130","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.regpep.2010.09.005","article-title":"Telmisartan attenuates aortic hypertrophy in hypertensive rats by the modulation of ACE2 and profilin-1 expression","volume":"166","author":"Zhong","year":"2011","journal-title":"Regul. Pept."},{"key":"10.1016\/j.yjmcc.2016.05.012_bb0135","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1161\/01.HYP.0000124667.34652.1a","article-title":"Upregulation of angiotensin-converting enzyme 2 after myocardial infarction by blockade of angiotensin II receptors","volume":"43","author":"Ishiyama","year":"2004","journal-title":"Hypertension"},{"key":"10.1016\/j.yjmcc.2016.05.012_bb0140","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1124\/mol.113.087122","article-title":"CYP2J2-derived epoxyeicosatrienoic acids suppress endoplasmic reticulum stress in heart failure","volume":"85","author":"Wang","year":"2014","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.yjmcc.2016.05.012_bb0145","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/ncb1137","article-title":"Mechanical stress activates angiotensin II type 1 receptor without the involvement of angiotensin II","volume":"6","author":"Zou","year":"2004","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.yjmcc.2016.05.012_bb0150","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1210\/me.2007-0312","article-title":"Differential bonding interactions of inverse agonists of angiotensin II type 1 receptor in stabilizing the inactive state","volume":"22","author":"Miura","year":"2008","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.yjmcc.2016.05.012_bb0155","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1124\/pr.112.007278","article-title":"A systematic comparison of the properties of clinically used angiotensin II type 1 receptor antagonists","volume":"65","author":"Michel","year":"2013","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.yjmcc.2016.05.012_bb0160","doi-asserted-by":"crossref","first-page":"19288","DOI":"10.1074\/jbc.M602144200","article-title":"Molecular mechanism underlying inverse agonist of angiotensin II type 1 receptor","volume":"281","author":"Miura","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.yjmcc.2016.05.012_bb0165","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1254\/jphs.09202FP","article-title":"Constitutively active mutant N111G of angiotensin II type 1 (AT1) receptor induces homologous internalization through mediation of AT1-receptor antagonist","volume":"111","author":"Bhuiyan","year":"2009","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.yjmcc.2016.05.012_bb0170","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1291\/hypres.26.937","article-title":"Molecular analysis of the structure and function of the angiotensin II type 1 receptor","volume":"26","author":"Miura","year":"2003","journal-title":"Hypertens. Res."},{"key":"10.1016\/j.yjmcc.2016.05.012_bb0175","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1124\/mol.105.011601","article-title":"Single mutations at Asn295 and Leu305 in the cytoplasmic half of transmembrane alpha-helix domain 7 of the AT1 receptor induce promiscuous agonist specificity for angiotensin II fragments: a pseudo-constitutive activity","volume":"68","author":"Feng","year":"2005","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.yjmcc.2016.05.012_bb0180","first-page":"113","article-title":"Impact of olmesartan on blood pressure, endothelial function, and cardiovascular outcomes","volume":"3","author":"Pimenta","year":"2010","journal-title":"Integr. Blood Press. Control."},{"key":"10.1016\/j.yjmcc.2016.05.012_bb0185","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.amjhyper.2004.07.021","article-title":"Role of angiotensin receptor blockers as monotherapy in reaching blood pressure goals","volume":"18","author":"Oparil","year":"2005","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.yjmcc.2016.05.012_bb0190","doi-asserted-by":"crossref","first-page":"B22","DOI":"10.1038\/nature00786","article-title":"Angiotensin-converting enzyme 2 is an essential regulator of heart function","volume":"417","author":"Crackower","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.yjmcc.2016.05.012_bb0195","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1111\/jcmm.12573","article-title":"Perinatally administered losartan augments renal ACE2 expression but not cardiac or renal Mas receptor in spontaneously hypertensive rats","volume":"19","author":"Klimas","year":"2015","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.yjmcc.2016.05.012_bb0200","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1161\/01.HYP.0000205833.89478.5b","article-title":"Deletion of angiotensin-converting enzyme 2 accelerates pressure overload-induced cardiac dysfunction by increasing local angiotensin II","volume":"47","author":"Yamamoto","year":"2006","journal-title":"Hypertension"},{"key":"10.1016\/j.yjmcc.2016.05.012_bb0205","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/j.amjhyper.2007.05.008","article-title":"Effects of aldosterone and angiotensin II receptor blockade on cardiac angiotensinogen and angiotensin-converting enzyme 2 expression in Dahl salt-sensitive hypertensive rats","volume":"20","author":"Takeda","year":"2007","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.yjmcc.2016.05.012_bb0210","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.tox.2011.11.008","article-title":"Candesartan cilexetil protects from cardiac myosin induced cardiotoxicity via reduction of endoplasmic reticulum stress and apoptosis in rats: involvement of ACE2-Ang (1\u20137)-mas axis","volume":"291","author":"Arumugam","year":"2012","journal-title":"Toxicology"},{"key":"10.1016\/j.yjmcc.2016.05.012_bb0215","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0066082","article-title":"Beneficial effects of the activation of the angiotensin-(1\u20137) MAS receptor in a murine model of adriamycin-induced nephropathy","volume":"8","author":"Silveira","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.yjmcc.2016.05.012_bb0220","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.lfs.2011.11.018","article-title":"Telmisartan acts through the modulation of ACE-2\/ANG 1\u20137\/mas receptor in rats with dilated cardiomyopathy induced by experimental autoimmune myocarditis","volume":"90","author":"Sukumaran","year":"2012","journal-title":"Life Sci."},{"key":"10.1016\/j.yjmcc.2016.05.012_bb0225","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1161\/CIRCHEARTFAILURE.108.840124","article-title":"Loss of angiotensin-converting enzyme 2 accelerates maladaptive left ventricular remodeling in response to myocardial infarction","volume":"2","author":"Kassiri","year":"2009","journal-title":"Circ. Heart Fail."},{"key":"10.1016\/j.yjmcc.2016.05.012_bb0230","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1291\/hypres.29.865","article-title":"Olmesartan is an angiotensin II receptor blocker with an inhibitory effect on angiotensin-converting enzyme","volume":"29","author":"Agata","year":"2006","journal-title":"Hypertens. Res."},{"key":"10.1016\/j.yjmcc.2016.05.012_bb0235","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/sj.jhh.1000788","article-title":"Dose-response efficacy of valsartan, a new angiotensin II receptor blocker","volume":"13","author":"Pool","year":"1999","journal-title":"J. Hum. Hypertens."},{"key":"10.1016\/j.yjmcc.2016.05.012_bb0240","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s00228-002-0456-3","article-title":"Effect of antihypertensive treatment with valsartan or atenolol on sexual activity and plasma testosterone in hypertensive men","volume":"58","author":"Fogari","year":"2002","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.yjmcc.2016.05.012_bb0245","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1291\/hypres.24.641","article-title":"Long-term effects of olmesartan, an Ang II receptor antagonist, on blood pressure and the renin-angiotensin-aldosterone system in hypertensive patients","volume":"24","author":"Ichikawa","year":"2001","journal-title":"Hypertens. Res."},{"key":"10.1016\/j.yjmcc.2016.05.012_bb0250","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1097\/00005344-200004000-00009","article-title":"Effects of angiotensin II type 1 receptor antagonist on nitric oxide synthase expression and myocardial remodeling in Goldblatt hypertensive rats","volume":"35","author":"Higashi","year":"2000","journal-title":"J. Cardiovasc. Pharmacol."}],"container-title":["Journal of Molecular and Cellular Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022282816301444?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022282816301444?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,8]],"date-time":"2019-09-08T07:19:46Z","timestamp":1567927186000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022282816301444"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":50,"alternative-id":["S0022282816301444"],"URL":"https:\/\/doi.org\/10.1016\/j.yjmcc.2016.05.012","relation":{},"ISSN":["0022-2828"],"issn-type":[{"value":"0022-2828","type":"print"}],"subject":[],"published":{"date-parts":[[2016,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The effects of different angiotensin II type 1 receptor blockers on the regulation of the ACE-AngII-AT1 and ACE2-Ang(1\u20137)-Mas axes in pressure overload-induced cardiac remodeling in male mice","name":"articletitle","label":"Article Title"},{"value":"Journal of Molecular and Cellular Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yjmcc.2016.05.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}